Start Date
August 31, 2003
Primary Completion Date
February 28, 2005
GABITRIL (tiagabine hydrochloride; CEP-6671)
Fieve Clinical Services, Inc., New York
Medical and Behavioral, New York
Medical Research Network, New York
Social Psychiatry Research Ins, Brooklyn
University of Pennsylvania, Philadelphia
Comprehensive Neuroscience Of, Falls Church
Richard Weisler, MD and Assoc, Raleigh
South East Health Consultants, Charleston
Carman Research, Smyrna
Clinical Neuroscience Solution, Jacksonville
Clinical Neuroscience Solution, West Palm Beach
Summit Research Network Farmin, Farmington Hills
Cunningham Clinical Research, Edwardsville
Claghorn-Lesem Research, Bellaire
Radiant Research Denver, Denver
Radiant Research Salt Lake, Salt Lake City
Pivotal Research Center, Mesa
Southwestern Research, Beverly Hills
Pharmacology Research Institut, Northridge
Radiant Research San Diego, San Diego
Affiliated Research Institute, San Diego
Pharmacology Research Institut, Newport Beach
Pacific Clinical Research Medi, Orange
Summit Research Network Inc., Portland
Summit Seattle Boren, Seattle
University of Connecticut, Farmington
Massachusetts General Hospital, Boston
CNS Research Institute, Clementon
Lead Sponsor
Cephalon
INDUSTRY